Telechem Arrayit has agreed to give Belmedtechnika the supply and licence rights for its microarray platform and associated reagents.
The Arrayit platform will enable Belmedtechnika to deploy Arrayit's massively parallel high-throughput genotyping platform to screen and test a large number of patient samples for disease-carrying traits quickly, affordably and accurately.
The agreement also gives Belmedtechnika the right to use Arrayit's contact printing technology for diagnostic applications.
